Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fenugreek extract is a concentrated preparation derived primarily from the seeds of Trigonella foenum-graecum, used as a dietary supplement for glycemic control, lactation support, lipid management, and other traditional indications. It contains steroidal saponins (e.g., protodioscin, dioscin), 4-hydroxyisoleucine, fibers, flavonoids, and other phytochemicals thought to contribute to effects such as slowing carbohydrate absorption, improving postprandial glycemia, and possible androgen-modulating and galactagogue activity. Evidence for lowering postprandial blood glucose is suggestive but mixed and of generally low quality; most other claimed uses lack high-quality confirmation. Safety concerns include gastrointestinal upset, hypoglycemia risk when combined with antidiabetic drugs, allergy (cross-reactivity with Fabaceae), potential interactions (e.g., warfarin potentiation, SSRIs with rare serotonin syndrome), and avoidance during pregnancy due to reported teratogenic risk at supplemental doses. It is not FDA-approved as a drug and is marketed as an herbal supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fenugreek extract.